Shilpa Gupta: We report for the 1st time the role of tumor fraction in ctDNA in patients with metastatic urothelial cancer in real world

Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared on X/Twitter:

“We report for the 1st time the role of tumor fraction in ctDNA in patients with metastatic urothelial cancer in real world.

• association with clinico-pathologic features and real world PFS
• prognostic biomarker
• may help personalize treatment
• prospective trials needed.”

View additional information.
Source: Shilpa Gupta/X